PureTech Health (PRTC) Treasury Shares (2022 - 2025)
PureTech Health (PRTC) reported Treasury Shares of $41.2 million for Q4 2025, up 187.82% year-over-year from $14.3 million in Q4 2024, and up 191.94% on a QoQ basis from -$44.8 million in Q2 2025.
PureTech Health (PRTC) has 3 years of Treasury Shares data on file, last reported at $41.2 million in Q4 2025.
- Quarterly Treasury Shares rose 187.82% year-over-year to $41.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $41.2 million (up 187.82% YoY) and the FY2025 annual result came in at $41.2 million, up 187.82% from the prior year.
- Treasury Shares grew to $41.2 million in Q4 2025 per PRTC's latest filing, from -$44.8 million in the prior quarter.
- Across five years, Treasury Shares topped out at $41.2 million in Q4 2025 and bottomed at -$46.9 million in Q4 2024.
- The 3-year median for Treasury Shares is -$9.1 million (2022), against an average of -$6.0 million.
- Peak annual rise in Treasury Shares reached 187.82% in 2025, while the deepest fall reached 187.82% in 2025.
- Tracing PRTC's Treasury Shares over 3 years: stood at $26.5 million in 2022, then tumbled by 276.9% to -$46.9 million in 2024, then surged by 187.82% to $41.2 million in 2025.
- Per Business Quant, the three latest PRTC Treasury Shares figures stand at $41.2 million (Q4 2025), -$44.8 million (Q2 2025), and -$46.9 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 700,000.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 34.70 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 41.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.15 Mn |
| Dec 31, 2025 | 41.15 Mn |
| Jun 30, 2025 | -44.76 Mn |
| Jun 30, 2025 | -44.76 Mn |
| Dec 31, 2024 | -46.86 Mn |
| Dec 31, 2024 | -46.86 Mn |
| Dec 31, 2022 | 26.49 Mn |
| Dec 31, 2022 | 26.49 Mn |